Cargando…

Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD

Alzheimer's disease (AD) is a major cause of dementia, disability, and death in the elderly. Despite recent advances in our understanding of the basic biological mechanisms underlying AD, we do not know how to prevent it, nor do we have an approved disease‐modifying intervention. Both are essen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oblak, Adrian L., Forner, Stefania, Territo, Paul R., Sasner, Michael, Carter, Gregory W., Howell, Gareth R., Sukoff‐Rizzo, Stacey J., Logsdon, Benjamin A., Mangravite, Lara M., Mortazavi, Ali, Baglietto‐Vargas, David, Green, Kim N., MacGregor, Grant R., Wood, Marcelo A., Tenner, Andrea J., LaFerla, Frank M., Lamb, Bruce T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683958/ https://www.ncbi.nlm.nih.gov/pubmed/33283040 http://dx.doi.org/10.1002/trc2.12110

Ejemplares similares

Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
por: Oblak, Adrian L., et al.
Publicado: (2021)

Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H
por: Kotredes, Kevin P., et al.
Publicado: (2021)

Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2(*)R47H
por: Kotredes, Kevin P., et al.
Publicado: (2022)

Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
por: Onos, Kristen D., et al.
Publicado: (2022)

A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
por: Preuss, Christoph, et al.
Publicado: (2020)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Javonillo, Dominic I., et al.
Publicado: (2022)

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Stimmell, Alina C., et al.
Publicado: (2019)

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
por: Forner, Stefania, et al.
Publicado: (2021)

Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model
por: Myczek, Kristoffer, et al.
Publicado: (2014)

Plcg2(M28L) Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
por: Oblak, Adrian L., et al.
Publicado: (2022)

Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice
por: Oblak, Adrian L., et al.
Publicado: (2022)

Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
por: Trujillo‐Estrada, Laura, et al.
Publicado: (2019)

Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer’s disease
por: Pandey, Ravi S., et al.
Publicado: (2023)

miR‐181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer’s disease
por: Rodriguez‐Ortiz, Carlos J., et al.
Publicado: (2020)

Determining the Role of ApoE4 in Age-Related Cerebrovascular Decline
por: Foley, Kate, et al.
Publicado: (2020)

Aging Related Transcriptomic Changes in the Mouse Models of Alzheimer’s Disease
por: Uyar, Asli, et al.
Publicado: (2020)

Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer’s disease
por: Martini, Alessandra C., et al.
Publicado: (2020)

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice
por: Hasegawa, Tohru, et al.
Publicado: (2010)

Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter Aβ or Tau Pathology
por: Castello, Nicholas A., et al.
Publicado: (2012)

Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
por: Sosna, Justyna, et al.
Publicado: (2018)

Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation
por: Onos, Kristen D., et al.
Publicado: (2019)

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
por: Baglietto‐Vargas, David, et al.
Publicado: (2018)

Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer’s disease mouse model
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease
por: Trujillo-Estrada, Laura, et al.
Publicado: (2021)

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease
por: Parachikova, Anna, et al.
Publicado: (2010)

A Trem2(R47H) mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques
por: Tran, Kristine M., et al.
Publicado: (2023)

Brain Gene Expression of a Sporadic (icv-STZ Mouse) and a Familial Mouse Model (3xTg-AD Mouse) of Alzheimer’s Disease
por: Chen, Yanxing, et al.
Publicado: (2012)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

The APOE(ε3/ε4) Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice
por: Foley, Kate E., et al.
Publicado: (2022)

Chronic Temporal Lobe Epilepsy Is Associated with Enhanced Alzheimer-Like Neuropathology in 3×Tg-AD Mice
por: Yan, Xiao-Xin, et al.
Publicado: (2012)

Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy
por: Asinof, Samuel K., et al.
Publicado: (2015)

Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss
por: Ager, Rahasson R., et al.
Publicado: (2015)

APOE ε4 and exercise interact in a sex‐specific manner to modulate dementia risk factors
por: Foley, Kate E., et al.
Publicado: (2022)

A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer’s Disease
por: Wang, Xulong, et al.
Publicado: (2018)

Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice
por: Van der Jeugd, Ann, et al.
Publicado: (2018)

Phasic Firing in Vasopressin Cells: Understanding Its Functional Significance through Computational Models
por: MacGregor, Duncan J., et al.
Publicado: (2012)

Emergent decision-making behaviour and rhythm generation in a computational model of the ventromedial nucleus of the hypothalamus
por: MacGregor, Duncan J., et al.
Publicado: (2019)

Spike Triggered Hormone Secretion in Vasopressin Cells; a Model Investigation of Mechanism and Heterogeneous Population Function
por: MacGregor, Duncan J., et al.
Publicado: (2013)

In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease
por: Lin, Alexander J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iprmhghbb87dcboviipa0286c7